The goal is to understand why inflammatory signaling is elevated and whether modifiable drivers are present: visceral fat, periodontal disease, poor sleep, alcohol, insulin resistance, autoimmune activity, environmental exposure, chronic infection, or unresolved cardiometabolic risk
Andersen, J
Microdosing GLP-1 for Autoimmune Conditions According to a comprehensive systematic review published in 2024, treatment with GLP-1 receptor agonists results in significant reductions in disease severity among patients with psoriasis
Its important to note that while glutathione supplementation has potential benefits, its effectiveness can vary based on individual health status, specific health conditions, dosage, and the form of supplementation
The collagen production stimulated by BPC-157 differs qualitatively from the disorganized scar tissue that often forms in chronic plantar fasciitis